We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Blood Test Detects Up to Five Infectious Diseases at POC

By LabMedica International staff writers
Posted on 12 May 2025

Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app. More...

This innovative process holds the potential to greatly accelerate diagnostics that traditionally take weeks, providing real-time data while being more cost-effective than current lab-based testing methods. Initially focusing on tuberculosis as a pilot case, the researchers designed the test, which operates similarly to a lateral flow device, to detect a variety of infections and, notably, to simultaneously identify multiple infections.

This research, conducted by Bangor University (Gwynedd, Wales) and Abertay University (Dundee, Scotland), utilized serum samples provided by the World Health Organization (WHO) from regions where TB is prevalent. The researchers created a prototype test by developing a new in-house method to produce antibody-coated gold nanoparticles, which are essential for the test’s effectiveness. The team then advanced the prototype into a multi-disease screening tool by designing a wax-printed background, which enabled the simultaneous testing of up to five different responses. This innovation allows for results to be delivered in just 15 minutes, significantly lowering the cost of testing.

The test demonstrated a sensitivity of 90% and a specificity of 63% in detecting TB, making it a reliable tool for identifying cases and providing an efficient screening method in remote areas. A smartphone application (RAP-TBS) was also developed to offer quantitative analysis of the test results. This means that the test can be performed directly in rural villages, delivering instant results and reducing the need for patients to travel long distances to access laboratory facilities, a common issue in countries with limited laboratory infrastructure. Moving forward, further research will focus on extending the shelf life of the detection reagents, enhancing precision, and collaborating with healthcare providers to integrate this tool into existing healthcare systems.

“With further development, this innovative device has real potential to provide a very rapid screening tool for the diagnosis not only of TB, but also of other significant human and animal infections caused by mycobacteria,” said Professor Mark Baird, Emeritus Professor at Bangor University. “TB remains one of the major causes of death worldwide, despite being both preventable and treatable and, with further development, this research has the potential to make a real impact. In many parts of the world, patients wait weeks—sometimes months—for a diagnosis, during which time infections can spread unchecked.”

“The development of this prototype blood test represents a significant leap forward in healthcare innovation, offering rapid detection and potentially life-saving diagnoses for multiple infectious diseases in remote areas,” added Professor Christopher Gwenin of Abertay Unversity who led the research. “Improving our ability to detect and treat cases of TB and the many other diseases that blight the developing world is an important stream of work and an area where further R&D investment is required to maintain momentum. The ability to detect TB rapidly could transform the diagnosis timeline and this is particularly vital in rural areas, where people lack access to adequate diagnostic services. Although still in the prototype phase, this research lays the groundwork for a scalable, mobile, and data-driven solution to tackle some of the world’s most persistent infectious diseases.”

Related Links:
Bangor University
Abertay University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Laboratory Software
ArtelWare
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.